Tag - medicine-4

 
Menu
Search
 
July 28, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE 4

Japan Times
COMMENTARY
Nov 3, 2021
Post-pandemic recovery must include the unpaid care economy
The unpaid care sector for the most part remains unaccounted for in standard government policy tools and its work is primarily performed by women.
Japan Times
WORLD / Science & Health
Nov 2, 2021
How often do COVID-19 vaccines cause heart problems in kids?
While the vaccines made by Pfizer-BioNTech and Moderna do seem to be associated with an increased risk of myocarditis, the absolute risk remains very small.
Japan Times
WORLD
Oct 30, 2021
Pfizer won the first round, but Moderna sees final victory ahead
Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company's mRNA technology gives it an advantage.
Japan Times
COMMENTARY / World
Oct 24, 2021
The overlooked victims of COVID-19: The children
The isolation measures imposed by the pandemic have severely curtailed social development in children, resulting in a wide array of mental, emotional and behavioral health issues.
Japan Times
COMMENTARY / World
Oct 24, 2021
A dangerous global divide on vaccine access
The inequitable vaccine divide leaves humanity far more vulnerable to the next stage of the pandemic, as well as to any other systemic crisis that may emerge.
Japan Times
WORLD
Oct 23, 2021
Benefits of Pfizer child shot likely outweigh risks, FDA says
Clearing a vaccine for elementary-school age children would mark a major milestone in the pandemic.
Japan Times
JAPAN / Explainer
Oct 20, 2021
Oral drug molnupiravir seen as 'trump card' in Japan's battle against COVID-19
The treatment developed by Merck could receive fast-track approval by the end of the year, and other oral drugs to fight the coronavirus are not far behind.
Japan Times
WORLD / Science & Health
Oct 19, 2021
What scientists know about the risk of breakthrough COVID-19 deaths
After former U.S. Secretary of State Colin Powell died Monday from COVID-19 complications, vaccine skeptics immediately seized on news that he had been vaccinated to stoke doubts.
Japan Times
WORLD
Oct 15, 2021
U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people
If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.
Japan Times
WORLD
Oct 14, 2021
Rush to buy Merck’s COVID-19 pill risks leaving poor countries behind
Despite efforts to license molnupiravir to generic-drug firms, the same risks of unequal distribution remain, says report.
Japan Times
WORLD / FOCUS
Oct 13, 2021
Why some nations using the same vaccines have deadlier COVID-19 outbreaks
Everything from dose intervals to the behavior of unvaccinated people has shaped the outcome of recent delta-driven waves in different countries.
Japan Times
WORLD
Oct 11, 2021
AstraZeneca drug effective at treating mild COVID-19 symptoms in trial
The antibody cocktail from AstraZeneca may offer a simple way of treating patients before they ever visit the hospital.
Japan Times
WORLD
Oct 11, 2021
Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor
Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, a data-tracking firm has said.
Japan Times
WORLD
Oct 8, 2021
Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11
The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.
Japan Times
BUSINESS / Companies
Oct 8, 2021
COVID-19 pill sales could hit $2 billion, drugmaker Shionogi says
Competition to snag a piece of the COVID pill market is fierce, as the world adjusts to the virus being endemic.
Japan Times
WORLD / Science & Health / FOCUS
Oct 7, 2021
A Chilean tree holds hope for new vaccines — if supplies last
Quillay trees, technically known as Quillaja saponaria, are rare evergreens native to Chile that have long been used by the indigenous Mapuche people to make soap and medicine.
Japan Times
WORLD / Science & Health
Oct 7, 2021
In major breakthrough, WHO backs malaria vaccine rollout for Africa's children
The WHO says 94% of malaria cases and deaths occur in Africa, a continent of 1.3 billion people.
Japan Times
JAPAN
Oct 4, 2021
Japan in talks to procure Merck oral drug for mild COVID-19 symptoms
Molnupiravir was seen to halve the likelihood of hospitalization or death, according to an interim analysis of clinical trials across areas including Japan, Europe and the U.S.
Japan Times
COMMENTARY / Japan
Oct 3, 2021
How Japan’s new PM can take a lead in improving global health
Prime Minister Suga's successor has a chance at becoming a global leader by helping end COVID-19 elsewhere in the world — a move that could also see Japan advance its foreign policy goals.
Japan Times
JAPAN
Oct 2, 2021
Japan urges prefectures to beef up medical systems ahead of winter virus wave
The health ministry has called for expanding the number of available beds nationwide on the assumption that the next wave of the virus could be at least as bad as this summer's fifth wave.
Japan's population continues to fall even as foreign resident count rises
The number of residents in Tokyo as of Jan. 1 rose by 0.03% from a year before, data shows, marking a year-on-year increase for the first time in three years, while the country's other 46 prefectures saw their populations continue to decline.
Ahead of the Olympics, Japan is still talking about the gymnast who won't be there
Japan's Shoko Miyata withdrew from the gymnastics team herself over her drinking and smoking, although it had already appeared as though the association was prepared to send her home from the team’s training camp in Monaco.
Yen melt-up nudges Japanese stocks into correction territory
Japanese stocks are down 10% from their July peak as the yen strengthens.
‘Crazy’ yen rally is at risk of shattering as soon as Wednesday
Some investors are warning that a yen rally is fragile, as was on show this week when the yen rapidly retraced an advance after Thursday’s stronger-than-expected U.S. economic growth figures.
Japan's average life expectancy rises for first time in three years
A decline in COVID-19-caused deaths likely helped boost the average life expectancy for Japanese men and women to rise for the first time in three years in 2023.
The Japanese Olympians looking to shine in Paris
Rim Nakamura, who is attempting to win Japan's first Olympic gold medal in cycling, will be one of the top Japanese athletes to watch at the Paris Games.
Japan’s minimum wage set for record ¥50 hike in major boost
Demonstrators rally to demand a big hike in minimum wages in Tokyo last week.
Japan loses top spot on strongest passport list to Singapore
Japan had the strongest passport for six years running from 2018, before being dethroned by Singapore on the 2024 list.
Why Japan's mysterious stash of classified funds escapes scrutiny
Prime Minister Fumio Kishida and Chief Cabinet Secretary Yoshimasa Hayashi (right) during a meeting in Tokyo on Tuesday.
Japan eyes gold — and the future — as Olympic men's soccer campaign begins
Japan midfielder Yu Hirakawa controls the ball during a match against the United States in Kansas City, Kansas, on June 11.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Traditional folk rituals like Mizudome-no-mai (dance to stop the rain) provide a sense of agency to a population that feels largely powerless in the face of the climate crisis.
As climate extremes intensify, Japan embraces ancient weather rituals
By Alex K.T. Martin

SUSTAINABLE JAPAN

JNTO promotes sustainable tourism initiatives
JNTO promotes sustainable tourism initiatives

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER